.

Xeris Pharmaceuticals Inc reported $-18916000 in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acelrx Pharmaceuticals ACRX:US $ -8672000 323K
Eli Lilly And LLY:US $ 1650.5M 919.4M
Horizon Pharma HZNP:US 147M 49.44M
JAZZ PHA JAZZ:US 126.35M 38.8M
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Pacira Pharmaceuticals PCRX:US $ 13.18M 8.55M
Perrigo Ordinary Shares PRGO:US $ 2.6M 20.5M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Teva Pharmaceutical Industries TEVA:US 734M 55M